Neoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q2 2022 Results - Earnings Call Transcript
Neoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Panbela Therapeutics, Inc.'s (PBLA) CEO Jennifer Simpson on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Biora Therapeutics, Inc's (BIOR) CEO Adi Mohanty on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Viridian Therapeutics, Inc. (VRDN) CEO Jonathan Violin on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Inhibikase Therapeutics, Inc. (IKT) CEO Milton Werner on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Bridge Investment Group Holdings Inc. (BRDG) CEO Jonathan Slager on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Tiptree Inc. (TIPT) CEO Jonathan Ilany on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha